The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Assessment of the effect of ethnicity on linifanib tolerability and pharmacokinetics in patients with cancer.
J. Xiong
Employment or Leadership Position - Abbott Laboratories
Stock Ownership - Abbott Laboratories
Y. Chiu
Employment or Leadership Position - Abbott Laboratories
Stock Ownership - Abbott Laboratories
R. S. Pradhan
Employment or Leadership Position - Abbott Laboratories
Stock Ownership - Abbott Laboratories
X. Li
Employment or Leadership Position - Abbott Laboratories
Stock Ownership - Abbott Laboratories
X. Li
Employment or Leadership Position - Abbott Laboratories
Stock Ownership - Abbott Laboratories
D. M. Carlson
Employment or Leadership Position - Abbott Laboratories
Stock Ownership - Abbott Laboratories
W. Awni
Employment or Leadership Position - Abbott Laboratories
Stock Ownership - Abbott Laboratories